Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBody odour is not listed as a recognised side effect of semaglutide in the official prescribing information, and clinical trials of Wegovy did not identify it as a reported adverse event. That said, some people using semaglutide do notice changes in how they smell, and there are plausible biological reasons why. Understanding the mechanism helps you tell apart a simple lifestyle adjustment from something worth mentioning to a clinician. These are prescription-only medicines assessed individually by a prescriber, so any persistent or unusual symptom is always worth raising at your next clinical review.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Search the prescribing literature for semaglutide and body odour and you'll find nothing, because it isn't there. The STEP 1 trial, which followed over 1,900 adults with obesity for 68 weeks, recorded side effects systematically, and changes in body scent were not among them. The clinical profile of semaglutide is dominated by gastrointestinal effects: nausea, diarrhoea, constipation and indigestion top the list, as the NHS medicines page for semaglutide confirms. Body odour simply doesn't appear in that picture.
That doesn't mean the people reporting it online are imagining things. It means the mechanism is almost certainly indirect, a downstream consequence of other well-documented changes rather than semaglutide acting on sweat glands directly. Working through the most plausible explanations is more useful than dismissing the question.
One quick check worth doing right now: look at how much water you've been drinking over the last 48 hours. Dehydration, which can follow a bout of nausea or diarrhoea in the early weeks of treatment, is one of the most straightforward contributors to concentrated sweat and altered breath. If your urine is darker than pale straw, that's your body telling you something before any odour does.
Rapid fat loss, regardless of how it's achieved, releases stored compounds as fat cells break down. Some of these compounds are volatile, they reach the skin surface and breath. People losing weight quickly through any method sometimes notice a temporary shift in how they smell, and those losing several percent of body weight over the first months of semaglutide treatment are no exception.
Diet changes play an equally important role. Semaglutide reduces appetite substantially, and many people on treatment find they eat far less, sometimes skipping meals or dropping to very low calorie intake without meaning to. A diet that has fallen very low in carbohydrates triggers ketosis, where the body burns fat for fuel and produces ketones, acetone being the one most associated with a distinctive sweet or chemical breath and, to a lesser extent, skin odour. This isn't dangerous in the short term, but it is a signal that calorie and carbohydrate intake may have dropped too far. A small consistent increase in complex carbohydrates usually resolves it within days.
Gut microbiome changes are a third factor. Changes in digestion and gut transit on semaglutide alter the bacterial environment in the bowel. Those bacteria produce gases and metabolites that affect breath and, indirectly, body scent. This is also temporary for most people, settling as the gut adapts to the slower gastric emptying that GLP-1 medicines produce.
Because the effect is indirect, the fixes are practical rather than medical. Prioritising hydration is the single most consistent recommendation: aim for clear to pale-yellow urine throughout the day, particularly in the weeks when GI side effects are most active. If nausea is making it hard to drink normally, sipping cool water steadily between meals tends to work better than trying to hit a volume in one go.
Protein intake matters too. Semaglutide's appetite suppression makes it easy to under-eat protein, and a diet very low in both protein and carbohydrates pushes the body harder into ketone production. Including a palm-sized portion of protein at each meal (even a small one) helps maintain muscle alongside the fat loss and keeps ketosis at bay for most people. Our overview of how Wegovy changes the body covers the metabolic shifts in more detail if you'd like to read further.
For those who notice breath changes specifically, timing matters: oral hygiene habits before bed (rather than just in the morning) catch the acetone-heavy period that often peaks overnight. None of this replaces clinical advice, if an odour change is significant, persistent beyond the first few weeks, or accompanied by other symptoms, it should go in front of a prescriber at the next review. Unexpected side effects during Wegovy treatment are worth logging and discussing, even when they seem minor.
Most scent changes on semaglutide are transient and lifestyle-linked. They tend to be most noticeable in the first four to eight weeks, the period when GI side effects are also at their peak and eating patterns are in the most flux. As the body adjusts to a lower calorie intake and the gut settles, the changes typically fade without specific intervention.
Reasons to raise it sooner rather than later include: a sweet or fruity odour that persists even after improving hydration and diet (it can occasionally signal a degree of ketoacidosis in people with diabetes, though this is rare with semaglutide alone), any sign of dehydration such as dizziness or dark urine that isn't improving with fluid intake, or odour changes accompanied by fever or unusual pain. The range of physiological effects semaglutide can have is worth understanding broadly, and our clinical team is available seven days a week for aftercare questions.
Understanding what semaglutide does to the body as a whole makes individual symptoms easier to interpret, and easier to put in perspective. If you're thinking about starting treatment and want to talk through what to expect, a free consultation with one of our prescribers is the place to begin. You can check your eligibility at any point without obligation. For a broader look at treatment costs and what's included, the Wegovy cost page sets it out plainly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.